Literature DB >> 12806250

Preformed silos in the management of gastroschisis: new progress with an old idea.

Marc Schlatter1.   

Abstract

Outcomes for infants with gastroschisis have paralleled advances made in neonatal intensive care and the use of parenteral nutrition. Mortality rates approaching 100% a half century ago are now closer to 2% to 8%. Further reduction in morbidity has been the focus of many studies during the past decade. Efforts have been made to identify factors associated with the development of gastroschisis and to evaluate the mode, timing, and location of delivery on the outcome of these infants. The effect of the mode and timing of definitive surgical repair has received attention by more recent reports of newer approaches, including the use of a preformed silo to provide coverage for the exposed viscera and allow a gradual reduction into the abdominal cavity.

Entities:  

Mesh:

Year:  2003        PMID: 12806250     DOI: 10.1097/00008480-200306000-00002

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  4 in total

1.  Risk stratification in gastroschisis: can prenatal evaluation or early postnatal factors predict outcome?

Authors:  Ryan P Davis; Marjorie C Treadwell; Robert A Drongowski; Daniel H Teitelbaum; George B Mychaliska
Journal:  Pediatr Surg Int       Date:  2009-03-10       Impact factor: 1.827

2.  Use of pulse oximeter placed on a gastroschisis silo to monitor intestinal oxygen saturation.

Authors:  Sunghoon Kim; James Betts; Steve Yedlin; Richard Rowe; Olajire Idowu
Journal:  Pediatr Surg Int       Date:  2006-07-27       Impact factor: 1.827

3.  Non-operative management of gastroschisis: a case-matched study.

Authors:  Arnaud Bonnard; Mohammed Zamakhshary; Nicole de Silva; J Ted Gerstle
Journal:  Pediatr Surg Int       Date:  2008-05-22       Impact factor: 1.827

Review 4.  Fetal counselling for congenital malformations.

Authors:  Kokila Lakhoo
Journal:  Pediatr Surg Int       Date:  2007-03-14       Impact factor: 2.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.